ExpreS 2 ion secures SEK 8 million in bridge financing to facilitate further growth

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that the Company is increasing its working capital by securing a combination of a bridge loan and a loan facility of up to SEK 8 million in total. This will enable ExpreS2ion to further expand its business activities in line with the growth numbers reported for Q1 and Q2 2019. The bridge financing is provided by Modelio Equity AB (publ), an investment company and shareholder in ExpreS2ion.Further information on the bridge financing The bridge financing consists of two parts; a loan of SEK 5 million and a loan facility of up to SEK 3